Sign Up

    ANTX

    COM:AN2THERAPEUTICS

    AN2 Therapeutics

    • Stock

    1.36

    −2.16%

    0.12

    USD last updated 08/04 01:51:35

    Last Close

    1.24

    07/04 20:00

    Market Cap

    40.93M

    Beta: -

    Volume Today

    69.82K

    Avg: -

    OverviewMetricsFinancialsAPI
    Income StatementBalance SheetCash FlowKey MetricsRatios
    Quarterly
    Yearly

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Dec '19
    Dec '20
    Dec '21
    Dec '22
    Dec '23
    average inventory
    average payables
    597.50K
    -
    1.59M
    166.53%
    2.40M
    50.64%
    average receivables
    700K
    -
    book value per share
    0.26
    -
    -1.45
    663.18%
    -2.61
    80.70%
    6.22
    337.87%
    5.28
    15.01%
    capex per share
    capex to depreciation
    capex to operating cash flow
    capex to revenue
    cash per share
    0.30
    -
    0.29
    3.01%
    3.23
    1,014.15%
    6.26
    93.99%
    4.55
    27.40%
    days of inventory on hand
    days payables outstanding
    days sales outstanding
    debt to assets
    0.00
    -
    0.00
    -
    debt to equity
    0.00
    -
    0.00
    -
    dividend yield
    0.01
    -
    earnings yield
    -0.02
    -
    -0.06
    221.96%
    -0.08
    22.28%
    -0.28
    269.02%
    -0.13
    52.81%
    enterprise value
    282.99M
    -
    212.26M
    24.99%
    267.26M
    25.91%
    119.03M
    55.46%
    467.92M
    293.13%
    enterprise value over ebitda
    -54.65
    -
    -29.14
    46.68%
    -12.39
    57.49%
    -2.82
    77.27%
    -6.72
    138.59%
    ev to operating cash flow
    -113.84
    -
    -39.57
    65.24%
    -13.05
    67.03%
    -3.56
    72.74%
    -8.78
    146.86%
    ev to sales
    free cash flow per share
    -0.13
    -
    -0.38
    187.84%
    -1.13
    195.73%
    -2.18
    93.17%
    -2.26
    3.51%
    free cash flow yield
    -0.01
    -
    -0.02
    187.84%
    -0.07
    195.73%
    -0.23
    212.15%
    -0.11
    51.86%
    graham net net
    0.25
    -
    -1.46
    680.02%
    -2.99
    104.81%
    5.79
    293.99%
    4.00
    31.03%
    graham number
    1.32
    -
    5.61
    325.82%
    8.34
    48.64%
    19.45
    133.07%
    18.06
    7.14%
    income quality
    0.44
    -
    0.39
    10.62%
    0.95
    141.13%
    0.82
    14.07%
    0.82
    0.76%
    intangibles to total assets
    0
    -
    0
    0
    0
    0
    interest coverage
    -82.22
    -
    interest debt per share
    0.00
    -
    0.04
    -
    inventory turnover
    invested capital
    0.00
    -
    0.00
    -
    market cap
    288.59M
    -
    216.33M
    25.04%
    279.35M
    29.13%
    146.19M
    47.67%
    483.57M
    230.78%
    net current asset value
    4.81M
    -
    -20.32M
    522.17%
    -52.62M
    158.97%
    91.43M
    273.76%
    96.46M
    5.50%
    net debt to ebitda
    1.08
    -
    0.56
    48.32%
    0.56
    0.35%
    0.64
    14.64%
    0.22
    65.04%
    net income per share
    -0.30
    -
    -0.97
    221.96%
    -1.18
    22.28%
    -2.70
    128.36%
    -2.74
    1.46%
    operating cash flow per share
    -0.13
    -
    -0.38
    187.84%
    -1.13
    195.73%
    -2.18
    93.17%
    -2.26
    3.51%
    payables turnover
    receivables turnover
    research and ddevelopement to revenue
    return on tangible assets
    -0.99
    -
    -3.21
    224.91%
    -0.33
    89.76%
    -0.40
    22.99%
    -0.47
    15.38%
    revenue per share
    roe
    -1.17
    -
    0.67
    157.17%
    0.45
    32.33%
    -0.43
    196.00%
    -0.52
    19.38%
    roic
    -1.07
    -
    0.36
    133.50%
    0.45
    26.56%
    -0.45
    198.76%
    -0.56
    24.66%
    sales general and administrative to revenue
    shareholders equity per share
    0.26
    -
    -1.45
    663.18%
    -2.61
    80.70%
    6.22
    337.87%
    5.28
    15.01%
    stock based compensation to revenue
    tangible asset value
    4.81M
    -
    -20.32M
    522.17%
    -47.41M
    133.33%
    95.37M
    301.16%
    124.70M
    30.75%
    tangible book value per share
    0.26
    -
    -1.45
    663.18%
    -2.61
    80.70%
    6.22
    337.87%
    5.28
    15.01%
    working capital
    5.54M
    -
    2.77M
    49.92%
    56.71M
    1,943.64%
    91.44M
    61.23%
    96.46M
    5.50%

    All numbers in USD (except ratios and percentages)